Cargando…
Preliminary Study on the Identification of BRAF(V600E) Mutation in Colorectal Cancer by Near-Infrared Spectroscopy
INTRODUCTION: In metastatic colorectal cancer (mCRC), the B-type Raf kinase (BRAF)(V600E) mutation is a molecular biomarker of poor prognosis and is of great importance to drug target. Currently, the commonly used methods for detecting BRAF(V600E) mutation include immunohistochemistry (IHC) and gene...
Autores principales: | Duan, Jiale, Yang, Yanping, Yin, Lei, Zhang, Xue, Tang, Yi, Zhang, Shuxian, Gong, Hanjuan, Xiao, Ming, Li, Ming, Li, Qingshu, Li, Xian, Yang, Lian, Fan, Qi, Wang, Yalan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764696/ https://www.ncbi.nlm.nih.gov/pubmed/33376356 http://dx.doi.org/10.2147/OTT.S287814 |
Ejemplares similares
-
Detection of the BRAF V600E Mutation in Colorectal Cancer by NIR Spectroscopy in Conjunction with Counter Propagation Artificial Neural Network
por: Zhang, Xue, et al.
Publicado: (2019) -
RHBDF2 is correlated with immune infiltrates in hepatocellular carcinoma and may have potential as a biomarker
por: Gong, Hanjuan, et al.
Publicado: (2023) -
BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013) -
Using Functional Near-Infrared Spectroscopy to Assess Brain Activation Evoked by Guilt and Shame
por: Duan, Lian, et al.
Publicado: (2020) -
Acquired resistance to BRAF inhibition in BRAF(V600E) mutant gliomas
por: Yao, Tsun-Wen, et al.
Publicado: (2016)